跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37,875 条关于
“Envision Pharma Group”
全部
37,875
临床试验
24,144
药物
1,627
机构
1,751
资讯
10,353
去年
Pooled Safety Analysis Highlights Tolerability of Trifluridine/Tipiracil Plus Bevacizumab in Metastatic Colorectal Cancer
上个月
WindRose Health Investors Recapitalizes Verified Clinical Trials, Appoints Howard Miller as CEO to Accelerate Growth
7个月前
Halo Pharma Emerges as Independent CDMO Following Noramco Group Divestiture to Siegfried
6个月前
JAMP Pharma Group Launches Generic Enzalutamide for Prostate Cancer Treatment in Canada
2个月前
Marchesini Group to Showcase Pharma and Aseptic Packaging Innovations at CPHI 2026 in Milan
2年前
UroGen Pharma's UGN-102 Shows Promise in Bladder Cancer Treatment
去年
Corcept's ALS drug trial disappoints, but zero deaths in high-dose group - FirstWord Pharma
去年
Pharma Equity Group Receives Regulatory Approval for Phase II Trial of RNX-011 in Secondary Peritonitis
去年
UGN-102 Demonstrates Durable Response in Recurrent Low-Grade Bladder Cancer
去年
UGN-102 Shows Durable Response in Low-Grade Bladder Cancer Trial
第 1 页,共 1036 页
上一页
下一页